Editing Post-traumatic stress disorder (section)

==== Prazosin ====
[[Prazosin]], an alpha-1 adrenergic antagonist, has been used in veterans with PTSD to reduce nightmares. Studies show variability in the symptom improvement, appropriate dosages, and efficacy in this population.<ref>{{cite journal |vauthors=Green B |s2cid=40069887 |title=Prazosin in the treatment of PTSD |journal=[[Journal of Psychiatric Practice]] |volume=20 |issue=4 |pages=253–9 |date=July 2014 |doi=10.1097/01.pra.0000452561.98286.1e |pmid=25036580}}</ref><ref>{{cite journal |vauthors=Singh B, Hughes AJ, Mehta G, Erwin PJ, Parsaik AK |title=Efficacy of Prazosin in Posttraumatic Stress Disorder: A Systematic Review and Meta-Analysis |journal=The Primary Care Companion for CNS Disorders |volume=18 |issue=4 |date=July 2016 |pmid=27828694 |doi=10.4088/PCC.16r01943 }}</ref><ref name="Waltman_2018">{{cite journal |vauthors=Waltman SM, Shearer D, Moore BA |title=Management of Post-Traumatic Nightmares: a Review of Pharmacologic and Nonpharmacologic Treatments Since 2013 |journal=[[Current Psychiatry Reports]] |publisher=Springer Science and Business Media LLC |volume=20 |issue=12 |date=2018-10-11 |issn=1523-3812 |pmid=30306339 |doi=10.1007/s11920-018-0971-2 |page=108 |s2cid=52958432}}</ref>